Starting Testosterone Gel in Men
Begin with testosterone gel 40.5 mg (two pump actuations or one 40.5 mg packet) applied once daily to the shoulders and upper arms, with dose titration based on testosterone levels checked after 1 week of treatment. 1, 2
Initial Dosing Strategy
The starting dose should be 40.5 mg daily for most men, which represents a middle-range dose that allows for both upward and downward titration based on response 2. While some formulations suggest starting at lower doses (20.25 mg), clinical experience and FDA labeling support 40.5 mg as a practical starting point that achieves therapeutic levels more reliably 2, 3.
Application Site and Technique
Apply exclusively to the shoulders and upper arms - specifically the area that would be covered by a short-sleeve t-shirt 2. This is critical because:
- Do NOT apply to: abdomen, genitals, chest, armpits, or knees 2
- Application to upper arms/shoulders provides 30-40% better bioavailability compared to abdominal application 3
- The gel should be spread across the maximum surface area of both shoulders/upper arms 2
Application instructions:
- Apply to clean, dry, intact skin
- Wash hands immediately with soap and water after application 1, 2
- Allow site to dry completely before dressing (typically 2-3 minutes) 4
- Cover application sites with clothing once dry 1
- Avoid showering, swimming, or washing the site for at least 2 hours after application 1, 2
Critical Safety Warning for Transfer Prevention
Testosterone gel leaves residue that can transfer to women and children through skin contact, causing serious virilization 1, 2. Patients must:
- Cover application sites with a shirt after drying
- Wash application sites thoroughly with soap and water before any skin-to-skin contact
- Ensure children and women avoid contact with unwashed or unclothed application sites 1, 2
Monitoring and Dose Titration Plan
Initial Monitoring Timeline
Week 1-2: Check testosterone level after at least 1 week of treatment 5. For testosterone gel, levels can be checked at any time after 1 week of consistent use, as steady-state is achieved rapidly (within 1-2 days) 2, 4, 3.
Goal: Achieve mid-normal range testosterone levels (approximately 400-700 ng/dL) 1
Dose Adjustment Algorithm
Based on the testosterone level at 1-2 weeks 2:
- If testosterone >750 ng/dL: Decrease by 20.25 mg (one pump actuation)
- If testosterone 350-750 ng/dL: Continue current dose
- If testosterone <350 ng/dL: Increase by 20.25 mg (one pump actuation)
Recheck testosterone 2-4 weeks after any dose adjustment until stable therapeutic levels achieved 1, 6.
Comprehensive Monitoring Schedule
Baseline (before starting):
- Morning testosterone (two separate occasions to confirm diagnosis)
- Hematocrit
- PSA and digital rectal exam (if age ≥40 years with baseline PSA >0.6 ng/mL) 1, 6
At 3-6 months:
- Testosterone level (to confirm mid-normal range)
- Hematocrit
- PSA and digital rectal exam (if indicated by age/risk)
- Clinical assessment of symptom response and adverse effects 1, 6
Annually thereafter:
- Testosterone level
- Hematocrit
- PSA and digital rectal exam (per age-appropriate screening guidelines)
- Clinical symptom assessment 1, 6
Safety Monitoring Thresholds
Hematocrit Management
- Stop testosterone immediately
- Evaluate for hypoxia and sleep apnea
- Wait until hematocrit decreases to safe level
- Reinitiate at reduced dose
Baseline hematocrit >50% is a relative contraindication requiring further evaluation before starting therapy 1.
Prostate Monitoring Triggers for Urology Referral
Obtain urological consultation if: 1, 6
- PSA increase >1.4 ng/mL within any 12-month period
- PSA velocity >0.4 ng/mL per year (using 6-month level as reference)
- Abnormality on digital rectal examination
- AUA/IPSS symptom score >19
Common Pitfalls and How to Avoid Them
Pitfall #1: Checking testosterone levels too early
- Don't check before 1 week of consistent use - levels won't be at steady-state 5
Pitfall #2: Wrong application site
- Abdominal application reduces bioavailability by 30-40% 3
- Only shoulders and upper arms provide optimal absorption 2, 7
Pitfall #3: Inadequate transfer prevention counseling
- This is a serious safety issue - women and children exposed to residual gel can develop virilization 1, 2
- Emphasize washing sites before contact and covering with clothing
Pitfall #4: Not adjusting for individual response
- Some patients may need twice-daily dosing for more stable levels if they experience symptom fluctuations 8
- Consider more frequent dosing if peak-related side effects (acne, mood changes) or late-day symptom recurrence occurs
Pitfall #5: Continuing therapy without symptom improvement
- If testosterone levels normalize but symptoms don't improve after 3-6 months, discontinue therapy 9
- There is no benefit to continuing treatment in men who achieve target levels without clinical improvement